Prostate Cancer Nuclear Medicine Diagnostics Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 SPECT
1.2.3 PET
1.3 Market by Application
1.3.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Perspective (2018-2029)
2.2 Prostate Cancer Nuclear Medicine Diagnostics Growth Trends by Region
2.2.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Prostate Cancer Nuclear Medicine Diagnostics Market Dynamics
2.3.1 Prostate Cancer Nuclear Medicine Diagnostics Industry Trends
2.3.2 Prostate Cancer Nuclear Medicine Diagnostics Market Drivers
2.3.3 Prostate Cancer Nuclear Medicine Diagnostics Market Challenges
2.3.4 Prostate Cancer Nuclear Medicine Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Revenue
3.1.1 Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Nuclear Medicine Diagnostics Revenue
3.4 Global Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Ratio
3.4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2022
3.5 Prostate Cancer Nuclear Medicine Diagnostics Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Nuclear Medicine Diagnostics Product Solution and Service
3.7 Date of Enter into Prostate Cancer Nuclear Medicine Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Nuclear Medicine Diagnostics Breakdown Data by Type
4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Type (2024-2029)
5 Prostate Cancer Nuclear Medicine Diagnostics Breakdown Data by Application
5.1 Global Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size (2018-2029)
6.2 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2018-2023)
6.3 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size (2018-2029)
7.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2018-2023)
7.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2018-2023)
8.3 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size (2018-2029)
9.2 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2018-2023)
9.3 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2018-2023)
10.3 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Blue Earth Diagnostics
11.1.1 Blue Earth Diagnostics Company Detail
11.1.2 Blue Earth Diagnostics Business Overview
11.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.1.4 Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.1.5 Blue Earth Diagnostics Recent Development
11.2 PETNET Solutions
11.2.1 PETNET Solutions Company Detail
11.2.2 PETNET Solutions Business Overview
11.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.2.4 PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.2.5 PETNET Solutions Recent Development
11.3 Cardinal Health
11.3.1 Cardinal Health Company Detail
11.3.2 Cardinal Health Business Overview
11.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.3.4 Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.3.5 Cardinal Health Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Detail
11.4.2 Lantheus Medical Imaging Business Overview
11.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.4.4 Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.4.5 Lantheus Medical Imaging Recent Development
11.5 Jubilant Pharma
11.5.1 Jubilant Pharma Company Detail
11.5.2 Jubilant Pharma Business Overview
11.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.5.4 Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.5.5 Jubilant Pharma Recent Development
11.6 NCM-USA
11.6.1 NCM-USA Company Detail
11.6.2 NCM-USA Business Overview
11.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.6.4 NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.6.5 NCM-USA Recent Development
11.7 Progenics Pharma
11.7.1 Progenics Pharma Company Detail
11.7.2 Progenics Pharma Business Overview
11.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.7.4 Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.7.5 Progenics Pharma Recent Development
11.8 Telix Pharma
11.8.1 Telix Pharma Company Detail
11.8.2 Telix Pharma Business Overview
11.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.8.4 Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.8.5 Telix Pharma Recent Development
11.9 ImaginAb
11.9.1 ImaginAb Company Detail
11.9.2 ImaginAb Business Overview
11.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.9.4 ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.9.5 ImaginAb Recent Development
11.10 Theragnostics
11.10.1 Theragnostics Company Detail
11.10.2 Theragnostics Business Overview
11.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.10.4 Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.10.5 Theragnostics Recent Development
11.11 Novartis
11.11.1 Novartis Company Detail
11.11.2 Novartis Business Overview
11.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.11.4 Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.11.5 Novartis Recent Development
11.12 Alliance Medical
11.12.1 Alliance Medical Company Detail
11.12.2 Alliance Medical Business Overview
11.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.12.4 Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
11.12.5 Alliance Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of SPECT
Table 3. Key Players of PET
Table 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region (2018-2023)
Table 8. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region (2024-2029)
Table 10. Prostate Cancer Nuclear Medicine Diagnostics Market Trends
Table 11. Prostate Cancer Nuclear Medicine Diagnostics Market Drivers
Table 12. Prostate Cancer Nuclear Medicine Diagnostics Market Challenges
Table 13. Prostate Cancer Nuclear Medicine Diagnostics Market Restraints
Table 14. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Players (2018-2023)
Table 16. Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2022)
Table 17. Ranking of Global Top Prostate Cancer Nuclear Medicine Diagnostics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Prostate Cancer Nuclear Medicine Diagnostics Product Solution and Service
Table 21. Date of Enter into Prostate Cancer Nuclear Medicine Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Type (2018-2023)
Table 25. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Type (2024-2029)
Table 27. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Application (2018-2023)
Table 29. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Application (2024-2029)
Table 31. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 34. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 35. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 36. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 37. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 40. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 41. Blue Earth Diagnostics Company Detail
Table 42. Blue Earth Diagnostics Business Overview
Table 43. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product
Table 44. Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 45. Blue Earth Diagnostics Recent Development
Table 46. PETNET Solutions Company Detail
Table 47. PETNET Solutions Business Overview
Table 48. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product
Table 49. PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 50. PETNET Solutions Recent Development
Table 51. Cardinal Health Company Detail
Table 52. Cardinal Health Business Overview
Table 53. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product
Table 54. Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 55. Cardinal Health Recent Development
Table 56. Lantheus Medical Imaging Company Detail
Table 57. Lantheus Medical Imaging Business Overview
Table 58. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product
Table 59. Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 60. Lantheus Medical Imaging Recent Development
Table 61. Jubilant Pharma Company Detail
Table 62. Jubilant Pharma Business Overview
Table 63. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
Table 64. Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 65. Jubilant Pharma Recent Development
Table 66. NCM-USA Company Detail
Table 67. NCM-USA Business Overview
Table 68. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product
Table 69. NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 70. NCM-USA Recent Development
Table 71. Progenics Pharma Company Detail
Table 72. Progenics Pharma Business Overview
Table 73. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
Table 74. Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 75. Progenics Pharma Recent Development
Table 76. Telix Pharma Company Detail
Table 77. Telix Pharma Business Overview
Table 78. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
Table 79. Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 80. Telix Pharma Recent Development
Table 81. ImaginAb Company Detail
Table 82. ImaginAb Business Overview
Table 83. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product
Table 84. ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 85. ImaginAb Recent Development
Table 86. Theragnostics Company Detail
Table 87. Theragnostics Business Overview
Table 88. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product
Table 89. Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 90. Theragnostics Recent Development
Table 91. Novartis Company Detail
Table 92. Novartis Business Overview
Table 93. Novartis Prostate Cancer Nuclear Medicine DiagnosticsProduct
Table 94. Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. Alliance Medical Company Detail
Table 97. Alliance Medical Business Overview
Table 98. Alliance Medical Prostate Cancer Nuclear Medicine DiagnosticsProduct
Table 99. Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023) & (US$ Million)
Table 100. Alliance Medical Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type: 2022 VS 2029
Figure 2. SPECT Features
Figure 3. PET Features
Figure 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application in 2022 & 2029
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Prostate Cancer Nuclear Medicine Diagnostics Report Years Considered
Figure 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 10. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region: 2022 VS 2029
Figure 12. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Players in 2022
Figure 13. Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2022)
Figure 14. The Top 10 and 5 Players Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2022
Figure 15. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 16. North America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2018-2029)
Figure 17. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2018-2029)
Figure 21. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. France Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. U.K. Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Nordic Countries Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region (2018-2029)
Figure 29. China Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. South Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. India Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Australia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2018-2029)
Figure 37. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Share by Country (2018-2029)
Figure 41. Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Blue Earth Diagnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 44. PETNET Solutions Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 45. Cardinal Health Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 46. Lantheus Medical Imaging Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 47. Jubilant Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 48. NCM-USA Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 49. Progenics Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 50. Telix Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 51. ImaginAb Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 52. Theragnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 53. Novartis Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 54. Alliance Medical Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Industry Market Size
